InCarda Therapeutics Funding & Investors
InCarda Therapeutics, Inc. operates as a biotechnology company. The Company develops an inhaled therapy intended to treat paroxysmal atrial fibrillation. InCarda Therapeutics focuses on the development and commercialization of therapies for acute cardiovascular conditions.
incardatherapeutics.comTotal Amount Raised: $86,376,976
InCarda Therapeutics Funding Rounds
Series Unknown
$8,500,000
Series C
$30,000,000
Series C Investors
InnovivaDeerfield ManagementHealthCapMorningside Venture InvestmentsSeries B
$42,000,000
Series B Investors
HealthCapSofinnova PartnersMorningside VenturesDeerfield ManagementAsset Management VenturesSeries A
$5,000,000
Series A Investors
Morningside Private InvestorsSeries Unknown
$8,500,000
Series C
$30,000,000
Series C Investors
InnovivaDeerfield ManagementHealthCapMorningside Venture InvestmentsSeries B
$42,000,000
Series B Investors
HealthCapSofinnova PartnersMorningside VenturesDeerfield ManagementAsset Management VenturesSeries A
$5,000,000
Series A Investors
Morningside Private InvestorsSeed
$566,977
Debt Financing
$310,000
Funding info provided by Diffbot.